Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
US
|
Europe
|
Latin America
|
Asia Pacific
|
World
|
clinica
Regions - World
Brazil courts Iraq’s “valuable unexplored medtech market”
08 September 2011
Iraqi government officials are scheduled to hold a “technical meeting” with Brazilian medtech industry representatives next month in Brasilia to discuss potential supply co-operation agreements. So said the Brazilian industry association, ...
Boston Scientific takes Promus Element and Taxus Element to India
18 February 2011
Boston Scientific has launched its third-generation drug-eluting stents (DESs), Promus Element and Taxus Element, in India. The devices elute everolimus and paclitaxel, respectively. India is one of the fastest-growing DES markets in the world, ...
Tanzania issues consultation on device permits and GDP requirements
12 October 2010
The Tanzanian Food and Drugs Authority has issued two complementary draft guidelines to further the implementation of its new medtech regulatory framework. The first draft document describes the agency's processes and procedures for issuing licence ...
ALS: Synapse's breathing simulation device gets humanitarian approval, Brainstorm initiates stem cell trial
12 October 2010
The US FDA has granted a humanitarian use device approval for Synapse Biomedical's Neurx diaphragm pacing system (DPS) in amyotrophic lateral sclerosis (ALS). The device can be used to simulate a breathing motion in ALS patients who have ...
Study: Cepheid’s PCR test could “revolutionise” TB diagnosis
02 September 2010
An automated molecular test developed by Cepheid to diagnose tuberculosis (TB) has proven more sensitive than the conventional testing method in a study. As the new diagnostic, Xpert MTB/RIF, is simple to perform and can be used at the point of ...
 
Cuba and the importance of not knowing
10 June 2009
"Corazón que no ve, corazón que no siente." What you – and your heart – don't see and don't know, won't hurt you, they say. The sentiment could not be more poignant than in the context of Cuban healthcare – it has a particular twist or two, of a ...
 
Heart patch scammer tarnishes image of Israeli medtech industry 04 August 2009

We are by now used to the innovative and ingenious ideas that emerge from the Israeli medical devices industry. For example, Given Imaging’s PillCam endoscope and Haifa Technion-Israel Institute of Technology’s Gelrin bone glue have made global ...

Asia Regulatory Forum Update
02 June 2009
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System. In addition to the ...
Influenza A (H1N1): countries affected reaches 34
15 May 2009
Belgium today became the 34 th country to confirm a case of influenza A (H1N1) – swine flu. New cases were also reported for the first time this week in Cuba, Finland and Thailand. China and Hong Kong this week both reported their second confirmed ...
 
Vitamin D and the vasculature: can we teach an old drug new tricks?
13 May 2009
Background: Vitamin D is a steroid hormone known for its role in regulating levels of calcium and phosphorus. Vitamin D has important autocrine/paracrine roles and it is involved in vascular biology. Clinical studies have shown a relationship ...
Pharmacotherapy of age-related macular degeneration
12 May 2009
Background: Age-related macular degeneration is the leading cause of blindness in the developed world. The number of persons with vision loss from age-related macular degeneration is projected to increase dramatically over the next few decades. ...
New perspectives for the treatment options in spinal cord injury
12 May 2009
Spinal cord injury (SCI) is a serious clinical disorder that leads to lifetime disability for which no suitable therapeutic agents are available so far. Further research is needed to understand the basic mechanisms of spinal cord pathology that ...
 
 
COMPANY/ORGANISATION


Loading COMPANY/ORGANISATION ....
 
CONDITION


Loading CONDITION ....
 
GEOGRAPHY


Loading GEOGRAPHY ....
 
MEDICAL TECHNOLOGY


Loading MEDICAL TECHNOLOGY ....
 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm